Benjamin Frey

11.4k total citations · 1 hit paper
221 papers, 7.8k citations indexed

About

Benjamin Frey is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Benjamin Frey has authored 221 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Immunology, 68 papers in Oncology and 68 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Benjamin Frey's work include Cancer Immunotherapy and Biomarkers (50 papers), Effects of Radiation Exposure (46 papers) and Phagocytosis and Immune Regulation (29 papers). Benjamin Frey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (50 papers), Effects of Radiation Exposure (46 papers) and Phagocytosis and Immune Regulation (29 papers). Benjamin Frey collaborates with scholars based in Germany, China and United States. Benjamin Frey's co-authors include Udo S. Gaipl, Rainer Fietkau, Martin Herrmann, Franz Rödel, Rainer Fietkau, Luis E. Muñoz, Christina Janko, Lisa Deloch, Anja Derer and Oliver J. Ott and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Benjamin Frey

206 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines

2014 734 citations Benjamin Frey et al. profile →

Peers

Countries citing papers authored by Benjamin Frey

Since Specialization

Citations

This map shows the geographic impact of Benjamin Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Frey more than expected).

Fields of papers citing papers by Benjamin Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Frey. The network helps show where Benjamin Frey may publish in the future.

Co-authorship network of co-authors of Benjamin Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Frey. A scholar is included among the top collaborators of Benjamin Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Frey. Benjamin Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing offline magnetic resonance-guided prostate radiotherapy through dedicated imaging and deep learning-based automatic contouring of targets and neurovascular structures 2025 ·Physics and Imaging in Radiation Oncology ·Philipp Schubert, Matthias May, (unknown), (unknown), Jana Hutter, (unknown), (unknown), (unknown), Lisa Deloch, (unknown), (unknown), (unknown), Benjamin Frey, Udo S. Gaipl, (unknown), (unknown), Michael Uder, Christoph Bert, (unknown), Florian Putz	0
2	Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders– results from a prospective, randomized, placebo-controlled trial 2024 ·Frontiers in Immunology ·Anna-Jasmina Donaubauer, Ina Becker, (unknown), Reinhard Voll, (unknown), (unknown), (unknown), Jian‐Guo Zhou, Rainer Fietkau, Udo S. Gaipl, Benjamin Frey	2
3	Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer – detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients’ peripheral blood 2024 ·Frontiers in Oncology ·Anna-Jasmina Donaubauer, Benjamin Frey, Manuel Weber, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarina Müller, Markus Eckstein, (unknown), (unknown), Thomas Weißmann, (unknown), Marco Kesting, Heinrich Iro, Udo S. Gaipl, (unknown), Antoniu‐Oreste Gostian	0
4	The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning 2024 ·Strahlentherapie und Onkologie ·Florian Putz, (unknown), Manuel Schmidt, Matthias May, (unknown), Thomas Weißmann, Philipp Schubert, (unknown), Ahmed M. Gomaa, (unknown), Sebastian Lettmaier, Benjamin Frey, Udo S. Gaipl, Luitpold Distel, Sabine Semrau, Christoph Bert, Rainer Fietkau, Yixing Huang	7
5	Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Pascal Irrgang, (unknown), (unknown), (unknown), (unknown), Michael Rückert, (unknown), Carol I. Geppert, Benjamin Frey, Wibke Bayer, Claudia Gravekamp, Matthias Tenbusch, Udo S. Gaipl, Dennis Lapuente	11
6	Flow cytometry-based monitoring of myeloid-derived suppressor cells in the peripheral blood of patients with solid tumors 2024 ·Methods in cell biology ·Anna-Jasmina Donaubauer, (unknown), Rainer Fietkau, Udo S. Gaipl, Benjamin Frey	1
7	Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy 2024 ·SHILAP Revista de lepidopterología ·Jian‐Guo Zhou, Jie Yang, Haitao Wang, Ada Hang‐Heng Wong, (unknown), Xiaofei Chen, Sisi He, (unknown), Yunjia Wang, Benjamin Frey, Rainer Fietkau, Markus Hecht, Wen‐Zhao Zhong, (unknown), Udo S. Gaipl	1
8	TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy 2024 ·Journal for ImmunoTherapy of Cancer ·Shixiang Wang, Yi Xiong, (unknown), Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung‐Hung Luo, Markus Hecht, Benjamin Frey, Udo S. Gaipl, Xuejun Li, Qi Zhao, Hu Ma, Jian‐Guo Zhou	7
9	The Influence of Different Irradiation Regimens on Inflammation and Vascularization in a Random-Pattern Flap Model 2023 ·Journal of Personalized Medicine ·(unknown), (unknown), Raymund E. Horch, Luitpold Distel, Benjamin Frey, Ramona Erber, Andreas Arkudas	1
10	Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells 2023 ·Neoplasia ·(unknown), (unknown), (unknown), (unknown), (unknown), Thorsten Rieckmann, Markus Hecht, Antoniu‐Oreste Gostian, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl, Michael Rückert	2
11	Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design 2023 ·Cancers ·Thomas Weißmann, (unknown), Matthias May, Sebastian Lettmaier, (unknown), Lisa Deloch, (unknown), (unknown), Benjamin Frey, Udo S. Gaipl, Christoph Bert, Luitpold Distel, Franziska Walter, Claus Belka, Sabine Semrau, Heinrich Iro, Rainer Fietkau, Yixing Huang, Florian Putz	1
12	Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 Concentration 2022 ·Cells ·Lisa Deloch, Stephanie Hehlgans, Michael Rückert, Andreas Maier, (unknown), (unknown), (unknown), Thomas Weißmann, Michaela Seeling, Falk Nimmerjahn, Rainer Fietkau, Franz Rödel, Claudia Fournier, Benjamin Frey, Udo S. Gaipl	5
13	Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells 2022 ·Neoplasia ·(unknown), (unknown), Benjamin Frey, Jennifer A. Vu, Rainer Fietkau, Luitpold Distel, Markus Hecht	3
14	Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells 2021 ·International Journal of Molecular Sciences ·Sebastian Wimmer, Lisa Deloch, Michael Häder, Anja Derer, (unknown), Thomas Weißmann, Markus Hecht, Antoniu‐Oreste Gostian, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl	12
15	Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors 2021 ·Journal for ImmunoTherapy of Cancer ·Jian‐Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, Ina Becker, Sandra Rutzner, Markus Eckstein, Roger Sun, (unknown), Philipp Schubert, (unknown), Rainer Fietkau, Éric Deutsch, Udo S. Gaipl, Markus Hecht	40
16	Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy 2021 ·Cells ·Jian‐Guo Zhou, Bo Liang, Jianguo Liu, Su‐Han Jin, Sisi He, Benjamin Frey, Ning Gu, Rainer Fietkau, Markus Hecht, Hu Ma, Udo S. Gaipl	31
17	Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer—Comparison of a Prospective Trial with a Revised Simulated Contouring Approach 2021 ·Journal of Clinical Medicine ·Thomas Weißmann, (unknown), Florian Putz, Sebastian Lettmaier, Philipp Schubert, (unknown), Sabine Semrau, Antoniu‐Oreste Gostian, Maximilian Traxdorf, Sarina K. Mueller, Markus Eckstein, Matthias Hautmann, Jens von der Grün, Marlen Haderlein, Benjamin Frey, Udo S. Gaipl, Christoph Bert, Heinrich Iro, Rainer Fietkau, Markus Hecht	1
18	Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial 2020 ·Cancers ·Marlen Haderlein, (unknown), Oliver J. Ott, Sebastian Lettmaier, Markus Hecht, Sabine Semrau, Benjamin Frey, Claudia Scherl, Heinrich Iro, Marco Kesting, Rainer Fietkau	5
19	Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma 2016 ·Clinical Cancer Research ·Manuela Krumbholz, (unknown), (unknown), Tobias Bäuerle, (unknown), (unknown), Abbas Agaimy, Benjamin Frey, (unknown), Eva Wardelmann, Wolfgang Hartmann, Heribert Juergens, Uta Dirksen, Markus Metzler	61
20	Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model 2014 ·Brain Pathology ·Christina Stache, Annett Hölsken, (unknown), Andreas Heß, Markus Metzler, Benjamin Frey, Rudolf Fahlbusch, Jörg Flitsch, Michael Buchfelder, Rolf Buslei	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact